ASCVD is a type of heart disease caused by consistent high levels of bad cholesterol (LDL-C) in the blood that leads to the buildup of plaque on the walls of the arteries. The plaque buildup results in problems such as heart attack and stroke. For people with ASCVD, also referred to as “known heart disease,” it’s important to lower bad cholesterol.
At the same time, many ASCVD patients struggle to lower their bad cholesterol, no matter how hard they try. For people with high cholesterol, it can be challenging to follow a strict diet, exercise and medication routine, when faced with the realities of day-to-day life.
And even when taking statins, the most commonly prescribed treatment for lowering cholesterol, up to 80% of patients with ASCVD aren’t meeting their cholesterol target. Furthermore, up to two-thirds of patients stop taking statins within one year of starting treatment.
There have been recent options available in treating the millions of patients with ASCVD who are not getting their cholesterol low enough and keeping it low. Seth J. Baum, MD, cardiologist and Chief Medical Officer of Excel Medical Clinical Trials, will be available to discuss ways to keep your heart healthy and a new available treatment option.
Interview courtesy: Novartis Pharmaceuticals Corporation

#heart #month #healthy #habits #cholesterol #seth #baum #cardiologist #medical #novartis #pharmaceuticals #corporation #leqvio #disease #atherosclerotic #cardiovascular #ascvd #ldl #stroke #attack

The post February is Heart Month CREATING HEART-HEALTHY HABITS Ways to Lower “Bad Cholesterol When Your Best Isn’t Enough” appeared first on Good News!.

#peripheral #artery #disease #heart #attack #stroke #acute #limb #ischemia #lower #amputation #american #heart #association #geoffrey #barnes #healthcare #cardiovascular #janssen #pharmaceuticals

The post A PREVALENT CONDITION THAT CAN LEAD TO SERIOUS OUTCOMES MAY OFTEN GO UNDERDIAGNOSED & UNDERTREATED PERIPHERAL ARTERY DISEASE appeared first on Good News!.

Nearly 62 million adult Americans have high cholesterol[i], and that number is growing. Of these, up to 34 million people are on standard treatment, which typically includes statins, on top of diet and exercise. However, 1 in 4 still aren’t able to control their cholesterol and continue to have elevated LDL-C levels[ii], putting them at increased risk for cardiovascular disease – the #1 cause of death in the U.S.[iii] In fact, the Centers for Disease Control and Prevention (CDC) expects deaths from cardiovascular disease to increase by approximately 25% by 2030.[iv]

Additionally, up to 2 million people have genetically high cholesterol, also known as familial hypercholesterolemia (FH), which is harder to manage and puts them at up to 20-times higher risk for developing early heart disease in their 30s, 40s and 50s.[v],[vi]

People who require additional LDL-C lowering on top of statin therapy represent a high-risk population, who may need to consider other options when their cholesterol remains high despite standard treatment. Fortunately, there are non-statin treatment options that may help people reach their LDL-C goals.

As we approach February, American Heart Month, it’s important for people to think about their long-term health and how they can take care of their heart. Working with a healthcare provider to keep your cholesterol in check and finding a treatment option that helps you reach and maintain your goals are important ways people can take care of their health.

Katherine Wilemon from the FH Foundation, who had a heart attack at age 39 due to undiagnosed and unmanaged FH, and Dr. Pamela Taub, an Associate Professor of Medicine in the Division of Cardiovascular Medicine at the University of California San Diego, will be available to discuss the risks associated with poorly managed cholesterol, risk factors for FH and treatment approaches that can make a difference for people who struggle to reach their cholesterol goals.

Interview is courtesy: Esperion Therapeutics

The post FEBRUARY IS American Heart MONTH appeared first on Good News!.

JOINING US NOW DURING HEART HEALTH MONTH IS INTERVENTIONAL CARDIOLOGIST AND MEMBER OF THE ASSOCIATION OF BLACK CARDIOLOGISTS DR. WAYNE BATCHELOR TO TELL US A LITTLE MORE ABOUT CORONARY ARTERY DISEASE, AND TO SHARE SOME TIPS FOR LIVING A HEART HEALTHY LIFESTYLE.

BIO: Dr. Wayne Batchelor received his B.A. and Doctorate of Medicine degrees summa cum laude at Queen’s University in Kingston, Ontario in Canada. He then completed a Comprehensive Internal Medicine Residency and Fellowship in Adult Cardiology at the University of Toronto and a fellowship in Interventional Cardiology with a Master’s of Health Science Degree in Clinical Research at Duke University.
He is the incoming Director of Interventional Cardiology and Interventional Cardiology Research at the Inova Heart and vascular Institute in Fairfax, Virginia. He has served on the Medical Faculty as an Assistant Professor of Medicine at the University of Toronto and as Associate Professor of Medicine at the Florida State University College of Medicine and has practiced as an interventional cardiologist at St. Michael’s Hospital in Toronto, Ontario Canada and at the Tallahassee Memorial Hospital in Florida.
Dr. Batchelor has given numerous invited lectures, published over 75 peer-reviewed original abstracts/manuscripts, and contributed multiple book chapters. He is a Fellow of the American College of Cardiology and the Society for Cardiac Angiography and Interventions, and was selected to serve on the American College of Cardiology’s (ACC) D2B (Door to Balloon) Task Force, a national committee charged with improving the rapidity of care for heart attack victims across the U.S. He currently serves on the ACC’s Interventional Cardiology Sectional Leadership Council.
His primary expertise is in structural/valvular heart disease, coronary and peripheral arterial disease, carotid artery disease and clinical research in interventional cardiology. He was instrumental in starting the first structural/valvular heart program at Tallahassee Memorial Hospital and served as Chair of its Interventional Cardiology Council. He has a keen interest in radial artery access percutaneous coronary interventions and has performed more than 4,000 radial access coronary stent procedures.
During his career, he has been recognized as the recipient of a number of awards, including the Dr. and Mrs. Sydney P. Schiff Medal in Surgery, Nathan E. Berry Prize in Urology, Sopman Award for Clinical Excellence and Human Compassion, National Research Fellowship from the Heart and Stroke Foundation of Canada, and the Capital Medical Society’s Outstanding Physician of the Year Award in 2017.
He is certified by the American Board of Internal Medicine in Cardiovascular Disease with added qualifications in Interventional Cardiology.

The post CARDIOVASCULAR DISEASE IS THE LEADING CAUSE OF DEATH AND DISABILITY AMONG ALL AMERICANS, BUT BLACK MEN AND WOMEN ARE MORE LIKELY….. appeared first on Good News!.

He specializes in primary prevention, valvular disease, consultative cardiology, echocardiography and non invasive testing.

His office at 903 Park Avenue in Manhattan has old world charm, but utilizes the most cutting edge technology to assist in cardiac diagnosis. He has another office adjacent to Columbia University Medical Center, the hospital he is affiliated with.

He has been featured in several videos that are available online. One was done for the Joy of Giving Something foundation. He is also featured on two videos made by Scientific American about heart arrhythmias and heart monitors that are available on their website.

The post Dr. David Sherman is a cardiologist who is in his 25th year of practice in New York City. click for video & podcast… appeared first on Good News!.

The post Henny Rudansky appeared first on Good News!.